HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, announced it has released a new HTG EdgeSeq Mouse mRNA Tumor Response Panel available now in the United States and Europe. Continue reading→

Continue reading→

Get the information and watch the video to learn more about vaccines, symptoms, and who is at riskContinue reading→

Grant allows for development of new online platform which will be a cell phone app for pregnant women and new moms struggling with opioid addiction is helping them get to doctor appointments on time, chat online with counselors, message their physician and watch videos that teach them about changing their behavior.Continue reading→

Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief for the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has been selected to receive the 2019 Distinguished Public Service Award from the American Association for Cancer Research (AACR). The AACR is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer.Continue reading→

Nine-story hospital tower opens to patients April 22; community preview April 7Continue reading→

Donation to establish center at nursing school, initiative at Biodesign.
Continue reading→

TUCSON, Ariz., March 21, 2019 — After a worldwide search, the Critical Path Institute (C-Path) today announced it has appointed Joseph Scheeren, Pharm. D., as its new President and Chief Executive Officer. Scheeren previously served as Senior Advisor Research and Development for Bayer AG and has had a distinguished 36-year career in the pharmaceutical industry having held positions domestically and internationally in drug development and regulatory approval on three continents.

Continue reading→

LumosVar — a name inspired by Harry Potter — could help physicians provide genomic-based treatments for their patientsContinue reading→